Name | NEFROLAYN-OREL, OOO |
|---|
INN | 5702013401 |
|---|
KPP | 570201001 |
|---|
OGRN | 1165749055812 |
|---|
OKPO | 03212949 |
|---|
Address | 303852, Orlovskaya Oblast', g Livny, ul Oktyabr'skaya, d. D. 52B |
|---|
Phone | +7 (910) 747-35-02 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.10 | Core activity | Hospitals | | 86.21 | Additional activity | General practice | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 23.06.2016 |
|---|
|
NEFROLAYN-OREL, OOO (Oryol Oblast; INN 5702013401) was registered on 23 Jun 2016. The company's authorized capital as of July 1, 2012 was 100000 rub. Principal activities of NEFROLAYN-OREL, OOO: hospitals (86.10), general practice (86.21), other independent activities in health care (86.90.9). |
Economic indicators2024
Net loss (RAS) of NEFROLAYN-OREL, OOO dropped over 2024 by 19.99% to 9.54 million RUB from 11.92 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.82 times to 91.74 million RUB from 50.54 million RUB over 2023. 2023
Net loss (RAS) of NEFROLAYN-OREL, OOO increased 3.40 times to 11.92 million RUB from 3.51 million RUB over 2022, the company informed. Revenue increased in the accounting period by 17.86% to 50.54 million RUB from 42.88 million RUB over 2022. 2022
Net loss (RAS) of NEFROLAYN-OREL, OOO dropped over 2022 by 41.02% to 3.51 million RUB from 5.94 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 1.29% to 42.88 million RUB from 43.45 million RUB in 2021. 2021
Net loss (RAS) of NEFROLAYN-OREL, OOO increased by 14.29% to 5.94 million RUB from 5.20 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 1.86% to 43.45 million RUB from 44.27 million RUB in 2020. 2020
Net loss (RAS) of NEFROLAYN-OREL, OOO dropped over 2020 by 17.71% to 5.20 million RUB from 6.32 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 5.33% to 44.27 million RUB from 46.76 million RUB in 2019. 2019
Net loss (RAS) of NEFROLAYN-OREL, OOO increased by 10.76% to 6.32 million RUB from 5.71 million RUB over 2018, the company informed. Revenue increased in the accounting period by 38.57% to 46.76 million RUB from 33.75 million RUB over 2018. 2018
Net loss (RAS) of NEFROLAYN-OREL, OOO dropped over 2018 2.27 times to 5.71 million RUB from 12.95 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 34.27% to 33.75 million RUB from 25.14 million RUB over 2017; cost of goods sold decreased by 1.71% to 37.14 million RUB from 37.79 million RUB; sales loss decreased 2.31 times to 5.51 million RUB from 12.74 million RUB. 2017
Net loss (RAS) of NEFROLAYN-OREL, OOO increased 14.15 times to 12.99 million RUB from 918.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period 27.53 times to 25.14 million RUB from 913.00 thousand RUB over 2016; cost of goods sold grew 20.81 times to 37.87 million RUB from 1.82 million RUB; sales loss grew 14.04 times to 12.74 million RUB from 907.00 thousand RUB. 2016
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|